AEON Biopharma Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
AEON Biopharma granted RSUs covering 150,000 shares to one newly hired non-executive employee as a material inducement to employment. The award was approved October 5, 2026 under the 2025 Employment Inducement Incentive Award Plan and vests 25% annually beginning March 9, 2026's anniversary. The grant is routine Section 711 disclosure with no bearing on AEON's pursuit of full-label U.S.
Key figures
- Vesting
- 4 equal annual installments of 25% starting March 9, 2027
- Rsu shares granted
- 150000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.